Krista Savage, MS, CGC


Education: B.S., Biology, Marquette University, 2011, and M.S., Genetic Counseling, University of Cincinnati, 2014

Areas of Expertise: Neurogenetics, General Genetics, Healthy Genetics

Affiliations and Disclosures: Former employee and current stockholder of Invitae Corporation, Contractor for Synapticure & CareND, Contractor for My Gene Counsel, LLC, Contractor for SteadyMD, Inc., Contractor for Everly Health, Inc.

Licenses: AL, AR, CA, CT, DE, FL, GA, IA, ID, IL, IN, KY, LA, MA, MI, MN, MT, NE, ND, NH, NJ, NM, OH, OK, OR, PA, RI, SD, TN, UT, VA, WA, WI

Biography: Krista received her MS in genetic counseling from the University of Cincinnati in 2014 and is board certified. Krista has a deep knowledge and experience in neurogenetics, which began at the University of Texas in Houston, where she worked in the Department of Neurosurgery for over six years. Here, she worked with neurosurgeons and neuro-oncologists and provided genetic counseling for patients with brain aneurysms, cerebral cavernous malformations, and brain tumors. She also started a genetic counseling clinic for adults with a variety of neurogenetic conditions, including hereditary forms of neuropathy, neuromuscular conditions, ataxia, epilepsy, ALS, and dementia. 

In 2020, Krista joined Invitae Corporation to provide genetic counseling for patients who had received genetic testing through Invitae. First, she expanded Invitae’s current genetic counseling services to include genetic counseling for their neurology test menu for the first time. Next, she expanded services further to provide genetic counseling for multiple specialties, including neurology, cardiology, connective tissue disorders, ophthalmology, immunology, general genetics, whole exome sequencing, and proactive (healthy) genetics. 

Krista continues her passion for genetic counseling at Grey Genetics. She believes in providing personalized care and providing an environment where any question can be asked, no matter how big or seemingly small. Krista’s priorities are to focus on the areas that are most important to her patients and help make genetic information approachable and understandable for everyone. She is licensed in all states that have licensure requirements, making her available to speak with patients and family members, no matter where they live.

Selected Presentations:

  • Glaser, K. & Qualmann, K.: The ABCs of NDDs: Approaches, benefits, and considerations for genetic testing in neurodevelopmental disorders. Invitae-sponsored webinar for genetic counselor and healthcare provider audience. June 2022.
  • Qualmann, K.J.: Gene Therapy in Neurogenetics: Spinal Muscular Atrophy. Invited talk, Rice Medical Speaker Conference. Rice University, Houston, TX, January 2020.
  • Qualmann, K.J.: Genetics and Brain Tumors. Invited talk to Brain Tumor Patient Support Group. Mischer Neuroscience Institute & Memorial Hermann Hospital, Houston, TX, August 2015, April 2018.
  • Jackson, M., Dunbar, E.M., Qualmann, K.J. and Henson, J.W.: Tumor Predisposition and Genetic Risk Assessment in a Neuro-Oncology Practice. Sunrise Session, Society for Neuro-Oncology Annual Meeting, November 2016.
  • Qualmann, K.J.: Charcot-Marie Tooth Hereditary Neuropathy: Introduction to Genes and Inheritance. Invited talk to Charcot-Marie Tooth Patient Support Group. Memorial Hermann Hospital, Houston, TX, November 2015, March 2016.
  • Santiago-Sim, T. and Qualmann, K.J.: An Update on Brain Aneurysms. Invited talk to Brain Aneurysm Patient Support Group. Mischer Neuroscience Institute & Memorial Hermann Hospital, Houston, TX, July 2014.